|
|
|
Vol. 16, No. 24, pp. 3277-3289, December 15, 2002
1 Department of Cancer Biology, Dana-Farber Cancer Institute and Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115, USA; 2 Department of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts 02115, USA; 3 Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA; 4 Tufts University School of Veterinary Medicine, North Grafton, Massachusetts 01536, USA; 5 Biogen, Cambridge, Massachusetts 02142, USA
| |
ABSTRACT |
|---|
|
|
|---|
D-cyclins (cyclins D1, D2, and D3) are components of the core cell cycle machinery. To directly test the ability of each D-cyclin to drive development of various lineages, we generated mice expressing only cyclin D1, or only cyclin D2, or only cyclin D3. We found that these "single-cyclin" embryos develop normally until late gestation. Our analyses revealed that in single-cyclin embryos, the tissue-specific expression pattern of D-cyclins was lost. Instead, mutant embryos ubiquitously expressed the remaining D-cyclin. These findings suggest that the functions of the three D-cyclins are largely exchangeable at this stage. Later in life, single-cyclin mice displayed focused abnormalities, resulting in premature mortality. "Cyclin D1-only" mice developed severe megaloblastic anemia, "cyclin D2-only" mice presented neurological abnormalities, and "cyclin D3-only" mice lacked normal cerebella. Analyses of the affected tissues revealed that these compartments failed to sufficiently up-regulate the remaining, intact D-cyclin. In particular, we found that in cerebellar granule neuron precursors, the N-myc transcription factor communicates with the cell cycle machinery via cyclins D1 and D2, but not D3, explaining the inability of D3-only mice to up-regulate cyclin D3 in this compartment. Hence, the requirement for a particular cyclin in a given tissue is likely caused by specific transcription factors, rather than by unique properties of cyclins.
[Key Words: Cell cycle; D-cyclins; mouse development; cell proliferation]
| |
Introduction |
|---|
|
|
|---|
The key components of the core cell cycle machinery are proteins
termed D-type cyclins (Sherr and Roberts 1999
). Three
D-cyclins
cyclin D1, cyclin D2, and cyclin D3
operate in mammalian
cells. The three proteins are encoded by separate genes, but show
significant amino acid similarity (50%-60% identity throughout the
coding region; Inaba et al. 1992
; Xiong et al. 1992
). The levels of
D-cyclins are controlled largely by the extracellular environment.
Thus, D-cyclins are induced by mitogens, and their levels decline when mitogens are removed or when antimitogens are added (Matsushime et al.
1991
). For these reasons, D-cyclins are regarded as sensors of the
extracellular environment that link the mitogenic pathways to the core
cell cycle machinery. Once induced, D-cyclins associate with partner
cyclin-dependent kinases CDK4 and CDK6 and drive phosphorylation and
subsequent inactivation of the retinoblastoma tumor suppressor gene
product, pRB, and pRB-related proteins p107 and p130 (Matsushime et al.
1992
, 1994
; Bates et al. 1994
; Meyerson and Harlow 1994
). This, in
turn, causes release or derepression of the E2F transcription factors
and allows entry of cells into the S phase (Adams 2001
). Ectopic
expression of D-cyclins' inhibitor, p16INK4a, was shown to
block the proliferation of several cell types, underscoring a critical,
essential function for D-cyclins in cell cycle progression (Lukas et
al. 1995a
; Ortega et al. 2002
).
During mouse development, the three D-cyclins are expressed in a
dynamic and highly orchestrated fashion, often in mutually exclusive
cell types. For example, a rapid switch from cyclin D1 to cyclin D3
expression takes place during early differentiation of extraembryonic
mesoderm (Wianny et al. 1998
). Within the early embryo, cyclins D1 and
D2 display opposite, highly specific expression patterns in the
developing hindbrain, cyclin D1 being expressed in rhombomeres r4, r6,
and r7, whereas cyclin D2 is expressed only in r3 and r5 (Wianny et al.
1998
). This unique pattern of D-cyclin expression is also seen at later
stages of embryo development. For instance, in certain
mesenchymal-epithelial interactions, cyclin D1 is expressed
exclusively in the mesenchymal compartment, whereas cyclin D2 is
present only in the juxtaposed epithelium (Aguzzi et al. 1996
). In the
developing skin, cyclin D1 is present in keratinocytes and absent from
developing hair follicles, whereas the converse is true for cyclin D2
(Aguzzi et al. 1996
). Within the developing nervous system, cyclins D1
and D2 are expressed in distinct proliferating compartments (Aguzzi et
al. 1996
). In some stratified squamous epithelia and in columnar
gastrointestinal epithelium, cyclin D1 localizes to the proliferative
layers, whereas cyclin D3 is present in the adjacent compartments
where differentiation takes place (Bartkova et al. 1998
). Yet other
compartments express combinations of two or even all three D-type
cyclins (Tam et al. 1994
; Lukas et al. 1995b
; Bartkova et al. 1998
).
This specific, often mutually exclusive pattern of D-cyclin expression
is also preserved in several organs of the adult animals (Ravnik et al. 1995
; Robker and Richards 1998
).
In addition to their growth-promoting functions, D-cyclins were
suggested to play unique, nonredundant roles in promoting cell
differentiation of specific cellular compartments. For instance, the
role for cyclin D3 in muscle differentiation is suggested by the
observation that this cyclin is dramatically induced (>20-fold) when
myoblasts exit the cell cycle and fuse to form myotubes. High levels of
cyclin D3 persist in differentiated, quiescent myotubes. In stark
contrast, the levels of cyclin D1 and D2 decline, consistent with the
exit from the active cell cycle (Rao et al. 1994
; Kiess et al. 1995
;
Skapek et al. 1995
). Collectively, these observations suggest that each
of the three D-cyclins may play unique, tissue-specific functions.
To elucidate in vivo functions for the three D-cyclins in different
lineages, we and others previously generated mouse strains lacking each
of the D-cyclin genes (Fantl et al. 1995
; Sicinski et al. 1995
, 1996
;
E. Sicinska and P. Sicinski, in prep.). We found that these knockout
mice showed narrow, very restricted developmental abnormalities. Thus,
cyclin D1-deficient mice displayed reduced body size, a spastic
leg-clasping reflex, and some premature mortality within the first 3 wk
of life, which we interpreted as an indication of the developmental
abnormalities within the nervous system. Moreover, cyclin D1-deficient
mice displayed severely hypoplastic retinas and pregnancy-insensitive
mammary glands (Fantl et al. 1995
; Sicinski et al. 1995
). Cyclin
D2-deficient females are sterile, owing to the inability of the ovarian
granulosa cells to proliferate normally in response to the
follicle-stimulating hormone (FSH), and cyclin D2
/
males,
although fertile, display hypoplastic testes (Sicinski et al. 1996
).
Furthermore, cyclin D2-deficient animals show impaired proliferation of
peripheral B-lymphocytes (Lam et al. 2000
; Solvason et al. 2000
) and
mild cerebellar abnormalities (Huard et al. 1999
). Cyclin D3-deficient
mice, in turn, are also viable, and display lymphoid abnormalities (E. Sicinska and P. Sicinski, in prep.).
These single-knockout experiments are illuminating, but their analyses are greatly confounded by the presence of two remaining, intact D-cyclins, which may compensate for the ablated protein. We decided to reduce this complexity by creating mouse strains expressing only a single D-type cyclin. In doing so, we hoped to be able to directly test which proliferative and developmental functions can be executed solely by cyclin D1, D2, or D3.
| |
Results |
|---|
|
|
|---|
Generation of single-cyclin mice
To obtain mice expressing a single D-cyclin ("single-cyclin"
mice), we took advantage of cyclin D1
/
,
D2
/
, or D3
/
deficient animals, which we
previously generated (Sicinski et al. 1995
, 1996
). By crossing these
mice, we obtained double heterozygous (D1+/
D2+/
, D1+/
D3+/
, or
D2+/
D3+/
) or heterozygous/knockout
(D1+/
D2
/
, D1+/
D3
/
, or D2+/
D3
/
) animals. The
double heterozygous animals were indistinguishable from the wild-type
littermates, whereas heterozygous/knockout mice displayed phenotypic
abnormalities characteristic of individual single-knockout strains
(data not shown). Successive crosses of these mice yielded mice
expressing only cyclin D1 (double-knockout cyclin D2
/
D3
/
), only cyclin D2 (double-knockout cyclin
D1
/
D3
/
), or only cyclin D3
(double-knockout cyclin D1
/
D2
/
) animals.
Analyses of single-cyclin embryos
We first collected single-cyclin embryos and analyzed their development at embryonic day 13.5 (E13.5). At this point, the primary structures of all major organs are well established and easily discernible. Unexpectedly, we found that the single-cyclin embryos were indistinguishable from control littermates. Detailed histopathological examinations revealed essentially normal morphogenesis in all tissues (data not shown). Consistent with these observations, we found that the bromodeoxyuridine (BrdU) incorporation pattern in single-cyclin embryos was virtually identical to that seen in wild-type embryos, revealing normal proliferation rates (Fig. 1A-C).
|
To understand the molecular basis of this apparently normal development
in single-cyclin embryos, we determined the expression pattern of the
D-type cyclins in mutant embryos and compared it with that seen in
wild-type littermates. These analyses revealed that a cyclin that is
normally not expressed in a particular compartment (or expressed at low
levels) becomes reactivated in the corresponding compartment of
single-cyclin embryos. For instance, developing wild-type livers
express only trace levels of cyclin D2, whereas in livers of cyclin
D1
/
D3
/
mice, cyclin D2 becomes greatly
up-regulated (Fig. 2A). Likewise, developing spleens express cyclins D2 and D3, but only trace levels of
cyclin D1, whereas cyclin D1 is greatly up-regulated in this organ in
cyclin D2
/
D3
/
embryos (Fig. 2A). As a
consequence, in single-cyclin embryos the tissue-specific expression
pattern of D-cyclins is lost. Instead, single-cyclin embryos
ubiquitously express the remaining, intact D-cyclin in all tissues
(Fig. 2B). Collectively, these findings suggest that each of the
D-cyclins, when ubiquitously expressed, can afford normal proliferation
of the developing embryo. This, in turn, indicates that the functions
of the three D-cyclins, at least until this point of development, are
exchangeable. Alternatively, the development of certain tissues may
occur in a cyclin D-independent fashion.
|
In addition to activating CDK4 and CDK6 kinases, D-cyclins were shown
to titrate the p27Kip1 cell cycle inhibitor from cyclin
E-CDK2 complexes to cyclin D-CDK complexes, thereby triggering the
activation of the cyclin E-CDK2 holoenzyme (Cheng et al. 1999
; Sherr
and Roberts 1999
; Tsutsui et al. 1999
). For this reason, we
hypothesized that in addition to up-regulating the remaining D-cyclin,
single-cyclin embryos might also reduce the levels of p27Kip1
to ensure proper activation of the cyclin E-CDK2 kinase. To address this issue, we compared the levels of p27Kip1 in different
organs of wild-type and single-cyclin embryos. Consistent with our
hypothesis, we observed marked down-regulation of p27Kip1
protein in several organs of single-cyclin embryos (Fig. 2C). Importantly, our semiquantitative reverse-transcription-PCR analyses revealed similar levels of p27Kip1 transcripts in wild-type
and mutant tissues (data not shown), indicating that down-regulation of
p27Kip1 protein levels occurs at the posttranscriptional level.
The down-regulation of p27Kip1 might have caused nonphysiologic up-regulation of CDK2-associated kinase, thereby bypassing the requirement for D-cyclins in cell-cycle progression. To address this possibility, we prepared lysates from wild-type and single-cyclin embryos, immunoprecipitated CDK2, and determined associated kinase activity using histone H1 as a substrate. These analyses revealed normal CDK2-associated kinase activity in single-cyclin embryos (Fig. 2D). Collectively, we interpret these findings as an indication that the ubiquitous, global expression of the remaining D-cyclin, together with down-regulation of p27Kip1, affords normal activation of cyclin E-CDK2 kinase and allows normal proliferation of cells in single-cyclin embryos.
Phenotypes of single-cyclin mice
We next turned our attention to the appearance of single-cyclin
animals at later stages of embryonal development and in postnatal life.
First, we analyzed the development of mice expressing only cyclin D1
(cyclin D2
/
D3
/
animals). No live pups were
recovered at day 1 of postnatal life (P1). Analyses of embryos at
different stages of development revealed that cyclin D1-only embryos
died toward the end of pregnancy, with the longest survival at E18.5
(Fig. 3A; Table
1).
|
|
Histopathological analyses of mutant embryos revealed essentially
normal morphogenesis in all tissues except for the developing livers.
Analyses of this compartment demonstrated severely reduced numbers of
immature erythroid cells in cyclin D1-only livers at E16.5 (Fig. 3B,C).
Because fetal livers are the major source of erythropoiesis at this
stage of development, it was likely that observed abnormalities would
result in a profound anemia. To address this possibility, we collected
peripheral blood from mutant embryos and analyzed the numbers and
appearance of the mature (enucleated) erythrocytes. We found that the
number of red blood cells in the peripheral blood of mutant mice was
reduced nearly fourfold
(6.5 × 105 ± 1.6 × 105/µL, n = 6, in
D2
/
D3
/
mice vs.
23.9 × 105 ± 2.1 × 105/µL, n = 7, in
control embryos), revealing that cyclin D1-only animals developed a
severe anemia. Significantly, the size of enucleated red blood cells in
the peripheral blood was greatly increased (Fig. 3D), a megaloblastic
feature seen in anemias caused by impaired division of erythroid
precursors. Moreover, several immature forms of red cell lineage were
often observed in the peripheral blood of mutant animals (data not
shown), again pointing to impaired generation of red blood cells. These
findings, together with apparently normal development of all other
organs (data not shown), suggested that severe anemia was a cause of death.
Next, we analyzed the development of mice expressing only cyclin D2
(cyclin D1
/
D3
/
animals). We found that
these cyclin D2-only mice were born with nearly expected frequency
(Fig. 4A; Table 1). A great majority of
animals died by the end of the first day of life. Close examination of
cyclin D2-only pups revealed that they were unable to suckle and
presented empty stomachs. Moreover, the physiologic content of the
neonatal gastrointestinal tract, meconium, was often found in the lungs
of dead mutants (Fig. 4D,E), suggesting an acute asphyxiation caused by
meconium aspiration syndrome (Greenough 1995
). This nature of
phenotypic abnormalities points to abnormal neurological reflexes as a
cause of death.
|
A small fraction of cyclin D2-only mice escaped perinatal death and
survived up to 2 mo of life (Table 1). These mice were much smaller
than wild-type littermates (Fig. 4B). Despite being fed by liquid,
calorie-rich diet, cyclin D2-only mice ultimately failed to thrive and
died. This appearance of mutant mice resembles most affected cyclin
D1-deficient mice (Fantl et al. 1995
; Sicinski et al. 1995
). We presume
that combined deletion of the cyclin D1 and D3 genes exacerbates the
neurological phenotype of cyclin D1-deficient mice, leading either to
death within the first 24 h of life, or at a later stage.
Importantly, microscopic examination of organs derived from cyclin
D2-only mice revealed essentially normal, unperturbed morphogenesis in
all tissues analyzed. An exception to this rule was provided by the
observation that cyclin D1
/
D3
/
animals
displayed hypoplastic retinas, which closely resembled the retinas seen
in cyclin D1
/
mice (data not shown). Hence, cyclin D2
alone is sufficient to afford normal development in nearly all cellular compartments.
Lastly, we turned our attention to mice expressing only cyclin D3
(cyclin D1
/
D2
/
animals). These mice were
born with nearly the expected Mendelian ratio (Fig.
5A; Table 1) and were initially
indistinguishable from control littermates. However, by 1 wk of age it
became obvious that cyclin D3-only mice displayed retarded growth and
by 2 wk of age their weight was approximately one-third of that seen in wild-type littermates (2.9 g, n = 6, in cyclin D1
/
D2
/
mice vs. 7.9 g, n = 10, in control mice). A
neurological abnormality in cyclin D3-only mice was suggested by the
observation that these mice displayed greatly impaired coordination of
movements. In particular, when placed on their backs, cyclin D3-only
animals had great difficulty in regaining normal body position (Fig.
5B). The impairment of movements greatly diminished the ability of mutant mice to search and to compete for food, and most likely constituted the cause of death within the first 3 wk of life.
|
Histopathological examination of tissues derived from cyclin
D1
/
D2
/
animals provided an explanation for
the observed phenotype. Specifically, we found that cyclin D3-only mice
lacked normally developed cerebella. As evidenced in Figure 5C and D,
this organ was found only in a rudimentary form in cyclin D3-only
animals, explaining their inability to move in a coordinated fashion.
Detailed histopathological analyses revealed that the number of cerebellar folia was decreased and the existing folia were stunted with shallow interfolial clefts (Fig. 5C). Moreover, the thickness of the internal granular layer, where most of the cerebellar neuronal cell bodies reside, was severely diminished, whereas Purkinje cells did not form a proper layer but were instead scattered through the molecular and internal granular layers, contributing to the hypoplastic, disorganized appearance of mutant cerebella (Fig. 5D).
In mice, the most intensive proliferation of granule neuron precursors
and definitive formation of the cerebellum takes place within the first
2 postnatal weeks (Altman and Bayer 1997
). We found that the phenotype
of cyclin D3-only mice was obvious at postnatal day 7 (P7; data not
shown), consistent with the severe impairment of neuronal precursor
proliferation. Remarkably, all other tissues appeared normal in mutant
mice, except for hypoplastic retinas of cyclin D1
/
D2
/
mice, which closely resembled the retinas of cyclin
D1
/
animals (data not shown).
Molecular analyses of single-cyclin mice
The phenotypic analyses of single-cyclin mice, described above, revealed that each of the D-cyclins is sufficient to afford nearly normal development of the vast majority of tissues. In each case, however, we found a particular cellular compartment in which a given cyclin could not support normal development, leading to circumscribed but severe abnormalities. To gain a molecular understanding of this phenomenon, we decided to initially focus on cyclin D3-only mice.
First, we analyzed the expression of D-cyclins in various organs of cyclin D3-only animals. As expected, we found a global, ubiquitous expression of this cyclin (data not shown), explaining normal development of the majority of tissues in mutant animals.
We next turned our attention to the developing cerebella, an organ
where cyclin D3 failed to support normal development. Analyses of
wild-type cerebella revealed that the external granule layer, where
proliferation of cerebellar neuronal precursors takes place (Altman and
Bayer 1997
), expressed high levels of cyclin D1 and D2 but very little
cyclin D3 (Fig. 6A). Importantly, the
corresponding layer of cyclin D1
/
D2
/
mice
expressed only slightly up-regulated levels of cyclin D3 (Fig. 6A).
Hence, mutant granule cells fail to sufficiently up-regulate cyclin D3.
This, in turn, compromises the ability of these cells to proliferate
and results in a severe cerebellar hypoplasia. Consistent with this
idea, we found that the proliferation rate in the external granular
layer of cyclin D3-only cerebella was significantly reduced, as
compared with wild-type littermates (Fig. 6B).
|
To further extend these analyses, we prepared protein lysates from wild-type and cyclin D3-only cerebella and we determined the extent of pRB phosphorylation, using Western blotting. We found that a significant fraction of pRB was hyperphosphorylated in wild-type cerebella. In contrast, the majority of pRB in cyclin D3-only cerebella was found in a hypophosphorylated state (Fig. 6C). We concluded that the developing cerebellar granule precursors fail to sufficiently up-regulate cyclin D3, resulting in inability to phosphorylate pRB and, consequently, to drive normal S-phase entry.
N-myc and D-cyclins in cerebellar granule cells
The high expression levels of cyclins D1 and D2 in the developing
cerebella, together with inability of cyclin D1
/
D2
/
cerebella to up-regulate cyclin D3, suggested to us
that transcription factor(s) operating in cerebellar granule cells may
impinge on the cell cycle machinery via cyclins D1 and D2 but not D3.
The identity of one candidate transcription factor was provided by the
observation that conditional, neuronal-specific knockout of the N-myc
gene results in a cerebellar phenotype that is strikingly similar to
that seen in cyclin D1
/
D2
/
mice (Knoepfler
et al. 2002
). Consistent with these findings, N-myc, but not other
members of the Myc family, is specifically expressed in the
proliferating zone of the developing cerebellum (. These observations led us to hypothesize that the N-myc drives proliferation of cerebellar granule neuronal precursors by impinging on
cyclins D1 and D2. To test this hypothesis, we compared the expression
pattern of N-myc in the developing cerebella of wild-type and cyclin
D1
/
D2
/
mice. As expected, we found high
levels of N-myc in the external granule layer of wild-type animals
(Fig. 7A); this layer also expressed high
levels of cyclins D1 and D2 (Fig. 6A) and incorporated BrdU (Fig.
6B). Importantly, the corresponding layer of cyclin D1
/
D2
/
mice expressed equally high levels of N-myc (Fig.
7A), but only very low levels of cyclin D3 (Fig. 6A) and presented
greatly reduced proliferation rate (Fig. 6B). These observations are
consistent with the hypothesis that N-myc induces cyclins D1 and D2 in
wild-type cerebellum, but fails to up-regulate cyclin D3 in wild-type
or in mutant tissues.
|
To test this notion directly, we derived primary cell cultures from
neonatal cerebella of wild-type mice. The great majority (>85%) of
cells in these cultures correspond to granule neuronal precursors, and
the system has been validated to study proliferation and
differentiation of cerebellar neuronal precursors (Kenney et al. Kenney and Rowitch
2000
). Cells were infected with a retrovirus encoding N-myc, and the
levels of D-cyclins were determined 48 h after infection using Western
blotting. We found that ectopic expression of N-myc led to significant
up-regulation of cyclins D1 and D2. In marked contrast, the levels of
cyclin D3 remained unchanged (Fig. 7B). We concluded that in cerebellar
granule neuronal precursors, N-myc communicates with the cell cycle
machinery by inducing cyclins D1 and D2, but not cyclin D3.
Consequently, cyclin D1
/
D2
/
mice are
unable to up-regulate cyclin D3 in cerebellar granule neuronal
precursors, leading to severe cerebellar hypoplasia in cyclin D3-only animals.
Analyses of other compartments in single-cyclin mice
The analyses described above indicated that the phenotype of cyclin
D3-only mice can be traced to the inability of mutant cerebella to
sufficiently up-regulate the remaining, intact D-cyclin. We next asked
whether the same holds true for other cellular compartments that fail
to develop properly in cyclin D-deficient animals. First, we focused on
developing retinas, a tissue that is profoundly hypoplastic in cyclin
D1-deficient mice (Fantl et al. 1995
; Sicinski et al. 1995
) as well as
in cyclin D1
/
D2
/
and D1
/
D3
/
mice (Fig. 8A; data not
shown). We compared the expression pattern of D-cyclins in the retinas
of wild-type versus cyclin D2-only mice using in situ hybridization.
Adjacent sections were stained for BrdU, to mark the proliferative
layer. As reported earlier (Zhang et al. 1998
; Geng et al. 1999
), the
proliferative zone of wild-type retinas expressed very high levels of
cyclin D1 and virtually no cyclin D2. The retinas of cyclin D2-only
mice lacked cyclin D1, and expressed only slightly up-regulated levels
of cyclin D2 (Fig. 8A). However, the increased levels of cyclin D2 in
cyclin D2-only retinas were dramatically lower than that of cyclin D1
in the wild-type retinas. Importantly, unlike cyclin D1 in wild-type
retinas, which was mainly expressed within the proliferating,
BrdU-positive layer, the expression of cyclin D2 in cyclin D2-only
retinas was largely confined to the nonproliferating zone (Fig. 8A).
Thus, as was the case with cerebellar granule cells in cyclin D3-only
mice, proliferating neuroretinal precursors of cyclin D2-only mice fail
to sufficiently up-regulate the remaining D-cyclin, leading to a severe
hypoplasia in the affected tissue.
|
Lastly, we turned to developing fetal livers, where the erythroid
compartment is unable to develop normally in the absence of cyclins D2
and D3 (Fig. 3). We isolated cells from wild-type and cyclin D1-only
E14.5 livers and stained them with Ter119 antibody to distinguish
erythroid, Ter119+ cells from Ter119-negative hepatocytes.
Ter119+ cells were then flow-sorted, and the levels of
cyclins D3 and D1 were determined by Western blotting. These analyses
revealed that wild-type Ter119+ cells expressed cyclin D3 but
no cyclin D1. In contrast, erythroid cells isolated from cyclin
D2
/
D3
/
mice expressed no cyclin D3, and
showed no up-regulation of cyclin D1 (Fig. 8B). Hence, as was the case
with single-cyclin cerebella and retinas, cyclin D2
/
D3
/
erythroid cells fail to up-regulate cyclin D1,
resulting in severe hematopoietic deficiency.
| |
Discussion |
|---|
|
|
|---|
It is well established that the D-cyclins are the recipients of numerous mitogenic and oncogenic signals. An important, unresolved question is whether each of the three D-type cyclins performs unique, possibly tissue-specific roles, or the functions for these proteins are fully overlapping.
The highly orchestrated, often mutually exclusive expression pattern of
the three D-cyclins during development and in adult tissues raises the
possibility that the D-cyclins may perform unique functions in
different cellular compartments (Tam et al. 1994
; Ravnik et al. 1995
;
Aguzzi et al. 1996
; Bartkova et al. 1998
; Doglioni et al. 1998
; Robker
and Richards 1998
; Wianny et al. 1998
). This notion is further
supported by the observations that ectopic expression of cyclin D1, but
not D3, prevents myogenic differentiation (Rao et al. 1994
; Skapek et
al. 1995
), whereas forced expression of cyclins D2 and D3, but not D1,
blocks differentiation of granulocytes (Kato and Sherr 1993
). Although
the three D-cyclins show very high (75%-78%) amino acid identity
within the so-called cyclin-box, which mediates CDK binding, the extent
of homology outside this domain is only 39%-47% (Inaba et al. 1992
;
Xiong et al. 1992
). It is then possible that apart from driving the phosphorylation of the retinoblastoma protein, each of the D-cyclins may perform additional, nonredundant functions, possibly via
tissue-specific interactors. Indeed, D-cyclins were shown to interact
with the DMP1 transcription factor (Hirai and Sherr 1996
; Inoue and
Sherr 1998
) as well as with the estrogen receptor (Neuman et al. 1997
; Zwijsen et al. 1997
).
To address the specific roles for D-cyclins in development, we and
others previously generated mice lacking each of the D-cyclin genes
(Fantl et al. 1995
; Sicinski et al. 1995
, 1996
). We found that each of
these single-knockout mice displayed narrow, tissue-specific abnormalities. However, the analyses of these single-knockout mice were
confounded by the presence of two remaining D-cyclins. In the present
study, we reduced the complexity by generating mice that express only
cyclin D1, D2, or D3. This was accomplished by crossing single-knockout
mice and by generating double-knockout animals.
We expected that combined ablation of the two D-cyclin genes would lead to an early embryonic lethality. Contrary to our expectations, we found that single-cyclin mice develop normally until late gestation. Molecular analyses revealed that in mutant embryos the tissue-specific expression pattern of D-cyclins was lost, and that these embryos expressed the remaining D-cyclin in all tissues. This ubiquitous expression of cyclin D1, D2, or D3 afforded nearly normal development of all tissues. Moreover, even at later stages of life, the overwhelming majority of organs also developed without any detectable defects; cyclin D2-only and cyclin D3-only mice were born live, and a fraction of them survived until several weeks after birth. Thus, virtually normal development of many different organs can take place in the presence of a single D-cyclin. We interpret these findings as an indication that the functions for the three D-cyclins in driving development, proliferation, and differentiation of the overwhelming majority of cell types are exchangeable. An alternative explanation to be considered is that the development of some tissues may occur independently of the D-cyclins (see below).
Significantly, in each of the single-cyclin strains we found that the
remaining cyclin was not able to support the development of a
particular, highly selective compartment. In each case we were able to
trace the phenotype to the inability of the remaining, intact D-cyclin
to become up-regulated in the affected tissue. This suggests that the
requirement for a particular cyclin in a given tissue is likely caused
by specific transcription factors impinging on particular D-cyclins in
this tissue. Indeed, our molecular analyses revealed that the N-myc
transcription factor, which seems to drive proliferation of cerebellar
granule neuron precursors (Kenney et al. 2003; Knoepfler et al. 2002
),
can communicate with the cell cycle machinery in these cells via
cyclins D1 and D2, but not D3, explaining the inability of cyclin
D1
/
D2
/
mice to up-regulate cyclin D3 in
this tissue. Consistent with this idea are recent observations that
conditional ablation of N-myc in the developing cerebellum causes a
profound reduction of cyclin D2 levels (the levels of cyclin D1 were
not analyzed; Knoepfler et al. 2002
), as well as earlier observations
that another member of the Myc family, namely, c-myc, can induce
cyclins D1 and D2 but not D3 in in vitro cultured murine fibroblasts
(Perez-Roger et al. 1999
). We presume that the inability of mutant
retinas and erythroid cells to sufficiently up-regulate the remaining D-cyclin can also be ascribed to a specific wiring of signal
transduction pathways to the cell cycle machinery. This idea is in
agreement with our earlier observations, that in mammary epithelial
cells, the Ras and Neu oncogenes can communicate with the cell cycle machinery only via cyclin D1, explaining the absolute dependency of
Ras- and Neu-driven oncogenic pathways on cyclin D1 (Yu et al. 2001
).
Hence, such rigid wiring of the signaling pathways to the core cell
cycle machinery, observed in some selected tissues, offers a window of
opportunity for therapeutic intervention in cancers deriving from these tissues.
Our analyses do not allow us to determine whether in these selected compartments, which rely on particular cyclins for development, the phenotypes observed in knockout mice can be solely attributed to an inability to up-regulate the remaining cyclin, or alternatively, reflect the existence of unique functions for D-cyclins. One way to conclusively address this issue is to create knock-in strains of mice in which the coding sequences for particular D-cyclins have been exchanged. These studies are in progress in our laboratory.
According to our present understanding, at least one D-cyclin is
required to afford proliferation of mammalian cells. This is based on
the presence of D-cyclins in all proliferating cell types and is
supported by the observations that ectopic expression of
p16INK4a blocks proliferation of several cell types grown in
vitro (Lukas et al. 1995a
; Sherr and Roberts 1999
). However, it was
reported that embryonic stem cells do not express D-cyclins, and are
not inhibited by p16INK4a expression (Savatier et al. 1996
),
raising the possibility that the D-cyclin
pRB pathway may not
operate in very early embryonic cycles and possibly in some other
tissues of the developing embryo. For this reason, the normal
development of certain compartments in single-cyclin mice might reflect
the fact that the development of these tissues proceeds in a cyclin
D-independent fashion. Combined ablation of the three D-cyclin genes
should conclusively address this issue.
The up-regulation of the remaining, intact cyclin, observed in several tissues of mutant mice, raises the possibility of the existence of a negative feedback loop, in which the major, dominant D-cyclin normally represses the expression of other cyclins. According to this scenario, genetic ablation of the major cyclin would relieve this repression, leading to up-regulation of the remaining D-cyclins. Although this scenario is entirely plausible, we found that the molecular mechanism of cyclin reactivation operates differently in distinct tissues of mutant mice. Thus, some tissues of single-cyclin mice up-regulate the mRNA encoding the remaining, intact cyclin, but others up-regulate the cyclin protein, without detectable changes at the RNA level (data not shown), pointing to a posttranscriptional mechanism. Hence, if such a feedback loop indeed exists, it operates through different mechanisms in various tissues. Moreover, our observation that ablation of D-cyclins leads to down-regulation of p27Kip1 raises the possibility that in addition to cross-regulating their own levels, D-cyclins may control the levels of p27Kip1. Hence, a network of positive and negative feedback loops may exist that cross-regulates the expression of D-cyclins and their interactors. Given the very frequent involvement of D-cyclins in human cancers, such networks represent potential targets for cancer therapies.
| |
Materials and methods |
|---|
|
|
|---|
Mice
Cyclin D1
/
, D2
/
, and D3
/
mice (Sicinski et al. 1995
, 1996
; E. Sicinska and P. Sicinski, in
prep.) were bred to generate double-heterozygous (D1+/
D2+/
, D1+/
D3+/
, D2+/
D3+/
) and heterozygous/knockout (D1+/
D2
/
, D1+/
D3
/
, D2+/
D3
/
) animals. These mice were then crossed, yielding
D1
/
D2
/
, D1
/
D3
/
, and D2
/
D3
/
animals.
Mice were genotyped by the PCR as described (Sicinski et al. 1995
,
1996
).
BrdU staining
Pregnant females or 5-day-old mice were injected intraperitoneally with bromodeoxyuridine (BrdU, Sigma) at 100 µg/g of body weight. E13.5 embryos, eyes dissected from E18.5 embryos, or postnatal cerebella were collected after 1 h and fixed in 4% paraformaldehyde in PBS. Five-micrometer-thick paraffin sections were stained with anti-BrdU antibody (Becton Dickinson), followed by detection with the Vectastain ABC kit (Vector Laboratories).
Western blot and kinase assays
Organs were dissected from embryos at E13.5-E18.5 or from mice at
days 1 or 5 after birth (P1 or P5), and protein lysates were prepared.
One-hundred micrograms of proteins was separated by 12% SDS-PAGE (or
6% for retinoblastoma protein analysis). In vitro cultured cerebellar
granule precursor cells were washed in PBS, scraped into lysis buffer,
and sonicated as described (Kenney and Rowitch 2000
). Twenty-five
micrograms of protein lysates was separated on 12.5% SDS-PAGE (or 8%
for N-myc analyses) and transferred to Immobilon-P membranes
(Millipore). The immunoblots were probed with the following antibodies:
anti-cyclin D2 (recognizing both cyclin D1 and D2; M-20; Santa Cruz
Biotechnology), anti-cyclin D3 (C-16; Santa Cruz Biotechnology),
anti-p27 (C-19; Santa Cruz Biotechnology), anti-pRb (245; PharMingen),
anti-N-myc (C-19; Santa Cruz), anti-actin (MAB1501, Chemicon
International), or anti-
-tubulin (DM 1A, Sigma). As secondary
antibodies, peroxidase-conjugated IgG (Bio-Rad) was used, followed by
chemiluminescence detection.
For kinase assays, 200 µg of protein lysates prepared from E13.5
embryos was incubated with anti-CDK2 antibody (M-2; Santa Cruz
Biotechnology) conjugated to agarose beads. Immunoprecipitates were
subjected to kinase reaction using histone H1 as a substrate as
described (Geng et al. 2001
). Controls included preincubation of
lysates in the presence of 15 µM roscovitine (Calbiochem) for 4 h,
followed by immunoprecipitation with anti-CDK2 antibody (in the
presence of 15 µM roscovitine) as well as immunoprecipitation with an
unrelated, control antibody (anti-progesterone receptor, C-19; Santa
Cruz Biotechnology).
Histopathologic analyses
Embryos or organs dissected from mice were fixed in Bouin's fixative (Sigma) and embedded in paraffin. Five-micrometer-thick sections were stained with hematoxylin and eosin. Peripheral blood was obtained from carotid arteries of viable E16.5 embryos. Blood smears were prepared using the wedge technique, followed by air-drying and Wright-Giemsa staining.
In situ hybridization
Eyes were collected from E18.5 embryos, and cerebella were
collected from 5-day-old mice and processed as described (Sicinski et
al. 1995
). Sections were hybridized with
-[35S]thio-UTP-labeled riboprobes specific for cyclin
D1, D2, D3, and N-myc as described (Sicinski et al. 1995
).
Flow-sorting of fetal livers
Livers were dissected from E14.5 mouse embryos, and single-cell suspensions were obtained. Erythroid cells were then stained with anti-mouse Ter119 antibody (Ly-76) coupled with phycoerythrin (Pharmingen), and Ter119+ cells were sorted using a MoFlo cell sorter (Cytomation). Protein lysates were immediately prepared from sorted cells; 50 µg of lysate was used for Western blot analyses.
Retroviral constructs
Mouse N-myc (Wood et al. 2000
) was cloned into the pWZL retroviral
vector. 293-EBNA (Invitrogen) packaging cells were cotransfected with
retroviral constructs, gagpol, and vesicular stomatitis virus G
glycoprotein plasmids, using Fugene 6 transfection reagent (Roche); 10 µg of each plasmid was used per transfection. Packaging cells were
refed 12 h after transfection. Retroviral supernatants were harvested
every 24 h for 72 h and stored at
80°C until use.
In vitro culture and infection of cerebellar granule neuron precursors
Cerebella from 4- to 5-day-old Swiss-Webster mice were dissected,
and cerebellar granule cell cultures were established essentially as
described (Kenney and Rowitch 2000
). Briefly, cell suspensions were
plated at the density 3 × 105 cells/cm2 onto
poly-DL-ornithine-coated plastic plates in Dulbecco's modified Eagle's medium F-12 (DMEM-F-12) containing 15 mM HEPES, L-glutamine, pyroxidine hydrochloride (GIBCO), N2 supplement (GIBCO), 10% fetal calf serum, 25 mM KCl, penicillin, streptomycin, and 1.5 µg/mL of
biologically active, unmodified N-terminal fragment of Sonic hedgehog
(Shh, Biogen Inc.). Cells were permitted to adhere during the 6-8-h
period of incubation in 37°C at 0.5% CO2. For 24 h prior to retroviral infection, cells were incubated in serum-free DMEM-F12 supplemented with 2 mM KCl, N2 supplement, antibiotics, and 3 µg/mL
of Shh. For infections this medium was removed and saved, then cells
were exposed to retroviral supernatants for 2-3 h. Supernatants were
removed, and conditioned medium was readded. Medium was supplemented
with 1 µg/mL of cyclopamine, to inhibit the action of Shh. Control
cultures were treated with noninfectious conditioned packaging cell
medium. Cells were harvested 48 h after infection.
| |
Acknowledgments |
|---|
We thank the members of the Sicinski lab and Jola Polanowska for help and advice. The work reported in this paper was undertaken during the tenure of a Research Training Fellowship awarded by the International Agency for Research on Cancer and The Kosciuszko Foundation Fellowship to M.A.C. A.M.K. is supported by a Fellowship from The Medical Foundation, Inc. (Boston, MA). D.H.R. acknowledges the NINDS, the National Multiple Sclerosis Society, and the McDonnell Foundation for support. P.S. held a Barr New Investigator Award. The work was supported by NIH grant 1R01CA85296 and the American Cancer Society grant RPG-99-042-01-CCG (to P.S.).
The publication costs of this article were defrayed in part by payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 USC section 1734 solely to indicate this fact.
| |
Footnotes |
|---|
Received July 15, 2002; revised version accepted October 25, 2002.
6 Present address: Department of Embryology, Institute of Zoology, University of Warsaw, Miecznikowa 1, 02-096 Warsaw, Poland.
7 Corresponding author.
E-MAIL peter_sicinski{at}dfci.harvard.edu; FAX (617) 632-5006.
Article and publication are at http://www.genesdev.org/cgi/doi/10.1101/gad.1023602.
| |
References |
|---|
|
|
|---|
Prevention and treatment.
Early Hum. Dev.
41:
183-192[CrossRef][Medline].